Eagle Pharmaceuticals (EGRX) Stock Chart & Stock Price History $1.65 -0.29 (-14.95%) As of 05/21/2025 03:59 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsSustainabilityTrendsBuy This Stock Eagle Pharmaceuticals Stock Price Performance The Eagle Pharmaceuticals (EGRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 56.69%, with a year-to-date return of 230.00%. In the past month, the stock has remained steady at 0.00%, reflecting recent market activity. As of the latest close, Eagle Pharmaceuticals traded at $1.65 with a market cap of $21.43 million and volume of 8,423 shares. Five years ago, the stock traded at $53.21, representing a 96.90% decrease over that period. At the time, it had a market cap of $728.45 million and a volume of 77,700 shares. Receive EGRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-14.95%1 Month Performance0.00%3 Month Performance+10.74%Year-To-Date Performance+230.00%1 Year Performance-56.69%5 Year Performance-96.90% EGRX Stock Chart for Thursday, May, 22, 2025 EGRX Chart by TradingView Eagle Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$1.94$1.65-14.95%$1.94$1.508,423 shs$21.43 million05/20/2025$1.94$1.94$1.94$1.8211,960 shs$25.20 million05/19/2025$1.94$1.94$1.94$1.8211,960 shs$25.20 million05/16/2025$1.94$1.94$1.94$1.803,275 shs$25.20 million05/15/2025$1.94$1.94$1.94$1.803,275 shs$25.20 million05/14/2025$1.97$1.94-1.52%$1.94$1.941,514 shs$25.20 million05/13/2025$1.99$1.97-1.01%$1.97$1.602,317 shs$25.58 million05/12/2025$1.99$1.99$1.99$1.55754 shs$25.84 million05/09/2025$1.90$1.99+4.74%$1.99$1.70571 shs$25.84 million05/08/2025$1.90$1.90$1.90$1.751,601 shs$24.68 million Get the Latest News and Ratings for EGRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$1.90$1.90$1.90$1.751,601 shs$24.68 million05/06/2025$1.97$1.90-3.55%$1.90$1.75201 shs$24.68 million05/05/2025$1.97$1.97$1.97$1.601,692 shs$25.58 million05/02/2025$1.96$1.97+0.51%$1.97$1.601,692 shs$25.58 million05/01/2025$1.96$1.96$1.96$1.9614 shs$25.46 million04/30/2025$1.96$1.96$1.96$1.50808 shs$25.46 million04/29/2025$1.92$1.96+2.08%$1.96$1.50808 shs$25.46 million04/28/2025$1.70$1.92+12.94%$1.92$1.60616 shs$24.94 million04/25/2025$1.50$1.70+13.33%$1.90$1.7058,851 shs$22.08 million04/24/2025$1.97$1.50-23.86%$1.79$1.5030,505 shs$19.48 million04/23/2025$1.65$1.97+19.39%$2.00$1.7568,402 shs$25.58 million04/22/2025$1.80$1.65-8.33%$1.75$1.65501 shs$21.43 million04/21/2025$1.80$1.80$1.80$1.55280 shs$23.38 million Related Companies MGNX Stock Price Chart SAVA Stock Price Chart COYA Stock Price Chart GNLX Stock Price Chart OPTN Stock Price Chart CCCC Stock Price Chart HLVX Stock Price Chart CRBU Stock Price Chart CABA Stock Price Chart CRBP Stock Price Chart Receive EGRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EGRX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eagle Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eagle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EGRX Stock Free EGRX Stock Alerts